Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
Background: Imbalance between cell proliferation and apoptosis underlies the development of pulmonary arterial hypertension (PAH). Current vasodilator treatment of PAH does not target the uncontrolled proliferative process in pulmonary arteries. Proteins involved in the apoptosis pathway may play a...
Saved in:
Main Authors: | Isabel Blanco (Author), Maribel Marquina (Author), Olga Tura-Ceide (Author), Elisabet Ferrer (Author), Ana M. Ramírez (Author), Manuel Lopez-Meseguer (Author), Maria Callejo (Author), Francisco Perez-Vizcaino (Author), Victor Ivo Peinado (Author), Joan Albert Barberà (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension
by: Paula Poyatos, et al.
Published: (2023) -
Scontri tra spie agli inizi della guerra fredda l'Organisation Gehlen in Italia, 1946-1956
by: Lias Ceide, Sarah
Published: (2023) -
Novel Survivin Inhibitor YM155 elicits Cytotoxicity in Glioblastoma Cell Lines with Normal or Deficiency DNA-Dependent Protein Kinase Activity
by: Pei Chun Lai, et al.
Published: (2012) -
Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells
by: Noé Véronique, et al.
Published: (2008) -
La investigación cualitativa en España: de la vida política al maltrato del sentido
by: Peinado Anselmo
Published: (2002)